COMPOSITION, CONTAINING LITHOSPERMI RADIX EXTRACT AS ACTIVE INGREDIENT, FOR PREVENTING, ALLEVIATING, OR TREATING PERIPHERAL NEUROPATHY

The present invention relates to a composition for preventing, alleviating, or treating peripheral neuropathy, in particular, peripheral neuropathy induced by an anti-cancer agent (i.e., chemotherapy-induced peripheral neuropathy), comprising a Lithospermi Radix extract as an effective component. Sp...

Full description

Saved in:
Bibliographic Details
Main Authors YI, Jin-Mu, CHO, Eun-Sang, KIM, Jinhee, KIM, Youngah, KIM, No Soo, PARK, Jong-Shik, LIM, Chae Jun, LEE, You Jin, BANG, Ok-Sun
Format Patent
LanguageEnglish
French
German
Published 19.08.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a composition for preventing, alleviating, or treating peripheral neuropathy, in particular, peripheral neuropathy induced by an anti-cancer agent (i.e., chemotherapy-induced peripheral neuropathy), comprising a Lithospermi Radix extract as an effective component. Specifically, the Lithospermi Radix extract can relieve the suppressed growth of neurites caused by an anti-cancer agent while neither inducing any cytotoxicity in normal cells nor changing the unique cytotoxic potential of an anti-cancer agent in human cancer cells. In addition the Lithospermi Radix extract can efficiently lower the enhanced sensitivity to painful stimuli in peripheral neuropathic animals induced by an anti-cancer agent. Thus, the Lithospermi Radix extract can be advantageously used as an effective component of a composition for prevention, alleviation, or treatment of chemotherapy-induced peripheral neuropathy.
Bibliography:Application Number: EP20150891955